{
  "id": 2572330,
  "title": "Breakfast News: A Conversation With Ionis CEO",
  "url": "https://urgent.news/2026/08/22/breakfast-news-a-conversation-with-ionis-ceo-2572330",
  "topic": "finance",
  "section": "Finance & Markets",
  "published": "2026-08-22T11:50:00.000Z",
  "source": {
    "name": "Nasdaq Markets",
    "slug": "nasdaq-markets",
    "url": "https://www.nasdaq.com/articles/breakfast-news-conversation-ionis-ceo"
  },
  "original_language": "en",
  "account": null,
  "summary": "Aug. 22, 2026 Ionis silences disease at the source Biotech has been hot in 2026. The sector, tracked by the SPDR S&P Biotech ETF, (NYSEMKT: XBI) is up 39% year to date -- beating tech and running even with energy. But it's been volatile, too. Moderna's (NASDAQ: MRNA) 177",
  "key_points": [],
  "editors_take": null,
  "illustration": null,
  "coverage": {
    "outlets": 2,
    "also_reported_by": [
      {
        "outlet": "Motley Fool",
        "title": "Breakfast News: A Conversation With Ionis CEO",
        "url": "https://urgent.news/2026/08/22/breakfast-news-a-conversation-with-ionis-ceo",
        "published": "2026-08-22T11:30:00.000Z"
      }
    ]
  },
  "ai_generated": true,
  "disclaimer": "Summaries, key points and the editor’s take are written by software from other outlets’ reporting and may contain errors — always check the linked original."
}